Cover Image
市場調查報告書

戒煙輔助藥的全球市場: 趨勢及預測(2017年∼2022年)

Global Smoking Cessation Aids Market - Trend & Forecast (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 391363
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
戒煙輔助藥的全球市場: 趨勢及預測(2017年∼2022年) Global Smoking Cessation Aids Market - Trend & Forecast (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 205 Pages
簡介

戒煙輔助藥,是輔助個人戒煙的產品,基本上替代抽煙,不過,沒有抽煙的有害的影響。 根據WHO,香煙每年造成約600萬人死亡。約500萬個死者,是直接使用香煙,60萬人以上由於暴露於被動吸煙而死亡。全世界有10億人以上的吸煙者。吸煙者大部分住在低所得國或中所得國。由於吸煙者的人口增加,抽煙的危險性便增加,可見到戒煙輔助藥市場持續性的成長。尼古丁替代療法(NRT)在戒煙輔助藥中最受好評。

本報告提供全球戒煙輔助藥市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 關於報告
  • 調查方法

第2章 摘要整理

第3章 市場概要

  • 市場定義
  • 市場成長要素
    • 很多人都吸煙上癮
    • 對抽煙的危險性的認識
    • 禁止煙草製品的廣告
  • 開發平台 - 現在開發中的產品
  • 市場課題
    • 藥物的有害作用
  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 競爭
    • 新加入廠商的威脅
    • 替代品的威脅

第4章 市場區隔

  • NRT口香糖
  • NRT錠劑
  • NRT吸入器
  • NRT貼片
  • 噴霧
  • 藥物
  • 電子香煙
  • 其他

第5章 全球市場:地區形勢

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
  • 亞洲
    • 印度
    • 中國
    • 日本
    • 韓國
  • 其他地區

第6章 競爭性的景觀

  • 簡介
  • M&A
  • 擴張
  • 新產品的銷售
  • 合作

第7章 主要業者

  • Reckitt Benckiser Plc
  • Pfizer
  • GlaxoSmithKline Plc
  • Roche
  • Novartis
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd.
  • 武田藥品工業
  • NJOY

第8章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Description

The Global market for Smoking cessation Aids Market is expected to reach $XX by the end of 2020 growing at a CAGR of around XX% from 2015 to 2021. Smoking cessation aids are products that help an individual quite smoking. It is basically an alternative to smoking but not having any hazardous effects like that of smoking. According to WHO, Tobacco kills approximately 6 million individuals every year. Around 5 million deaths are due to direct tobacco use and more than 600000 deaths are as a result of exposure to second-hand smoke. There is more than 1 billion smoking/ tobacco users' worldwide. The majority of smokers live in low- or middle income countries. Due to large population of smoking individuals and increasing awareness of hazards of smoking there is a sustained growth in the market for smoking cessation aids. Nicotine replacement therapy (NRT) have gained the largest popularity as a smoking cessation aid.

The market for smoking cessation aids have been segmented into NRT Gums, NRT Lozenges, NRT Inhalers, NRT Patches, Sprays, Drugs and electronic cigarettes. Nicotine replacement therapy has the largest market segment with many OTC products. Amongst NRT products, NRT Gums has the largest share in the market. Amongst prescription products, inhalers, and sprays have the largest market. However, there is a rapid growth in electronic cigarettes, NRT lozenges, and NRT patches market due to ease of use. The drug therapy for Smoking cessation did not have a good impact. Amongst drugs Zyban by GSK and Chantix by Pfizer are used as first line therapy. However, due to many adverse effects of these drugs like suicidal tendency etc., there have been a decline in market of drug as a smoking cessation aid. The key players in smoking cessation therapy market are GlaxoSmithKline, Pfizer, Novartis, Johnson and Johnson, Cipla Ltd. And others.

Drivers

Large Tobacco Consuming Population, Awareness amongst Smokers on hazards of smoking, Banning of Tobacco product advertisement in many countries are the key factors augmenting the market as market driver.

Challenges

Adverse effect of drugs, is one the challenge that drug therapy market for Smoking cessation has witnessed.

What the report offers:

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for the Smoking cessation Aids Market, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares

5) Identification and analysis of the Macro and Micro factors that affect the Smoking cessation Aids Market on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

  • 1.1 Report Desciption
  • 1.2 Research Methodology

2. Executive Summary

3. Market Overview

  • 3.1 Market Definition
  • 3.2 Market Drivers
    • 3.2.1 Large Population Addicted to smoking
    • 3.2.2 Awareness on hazards of Smoking
    • 3.2.3 Banning Advertisements of Tobacco products
  • 3.3 Pipeline - Products currently in development
  • 3.4 Market Challenges
    • 3.4.1 Adverse effects of Drugs
  • 3.5 Porter's five forces for cord blood stem cell market
    • 3.5.1 Bargaining power of suppliers
    • 3.5.2 Bargaining power of buyers
    • 3.5.3 Competition
    • 3.5.4 Threats of new entrants
    • 3.5.5 Threats from substitutes

4. Market Segmentation

  • 4.1 NRT Gum
  • 4.2 NRT lozenges
  • 4.3 NRT Inhalers
  • 4.4 NRT Patches
  • 4.5 Sprays
  • 4.5 Drugs
  • 4.7 Electronic Ciggarettes
  • 4.8 Others

5. Global Market: Geographical Landscape

  • 5.1 North America
    • 5.1.1 USA
    • 5.1.2 Canada
    • 5.1.3 Mexico
  • 5.2 Europe
    • 5.2.1 UK
    • 5.2.2 Germany
    • 5.2.3 France
    • 5.2.3 Spain
  • 5.3 Asia
    • 5.3.1 India
    • 5.3.2 China
    • 5.3.3 Japan
    • 5.3.4 South Korea
  • 5.4 Rest of the World

6. Competitive landscape

  • 6.1 Introduction
  • 6.2 Mergers and Acquisition
  • 6.3 Expansion
  • 6.4 New Product Launch
  • 6.5 Colllaborations

7. Key Players

  • 7.1 Reckitt Benckiser Plc
  • 7.2 Pfizer
  • 7.3 GlaxoSmithKline Plc
  • 7.4 Roche
  • 7.5 Novartis
  • 7.6 Johnson and Johnson
  • 7.7 Bayer AG
  • 7.8 Cipla Ltd.
  • 7.9 Takeda Pharmaceuticals Co. Ltd.
  • 7.10 NJOY

8. Appendix

Back to Top